sambasivarao
☆    

2010-10-01 16:02
(5750 d 07:24 ago)

Posting: # 5971
Views: 9,306
 

 Appropriate Biological matrix for BA/BE studies [Bioanalytics]

What are the basics to be consider to choose Biological matrix for BA/BE studies pharmacokinetics analysis?

in other words

What is the criteria to choose matrix (plasma/serum/blood/urine) for bioanalysis?

Regards
Sambasivarao
Synapse Labs Ltd.
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2010-10-01 16:27
(5750 d 06:59 ago)

@ sambasivarao
Posting: # 5972
Views: 8,297
 

 Appropriate Biological matrix for BA/BE studies

Dear Sambasivarao!

❝ What is the criteria to choose matrix (plasma/serum/blood/urine) for bioanalysis?

  1. Pharmacokinetics of the drug.
  2. Bioanalytical constraints.
  • Urine is an acceptable matrix if the drug is mainly excreted unchanged renally. Due to improvements in bioanalysis urine is not a preferred matrix nowadays. If no characterization of the full time profile is possible (low concentrations in plasma) EMA recommends amount excreted in urine as the primary metric for extent of absorption, but still Cmax from plasma.
  • Whole blood makes only sense if the drug is extensively bound to erythrocytes and essentially no concentrations would be found in plasma (one of the rare examples is chlorthalidone).
  • Serum or plasma makes no big difference - if the drug is stable enough. It takes some time until blood clotes; if you centrifuge too early most likely you will experience turbid serum after thawing. Therefore most analysts opt for plasma even if the drug is stable at room temperature. You have to check during method development which type of anticoagulant (heparin, citrate, different EDTA-salts) is suitable, i.e., does not interfere with the extraction, separation, and detection.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Ohlbe
★★★

France,
2010-10-01 16:39
(5750 d 06:47 ago)

@ Helmut
Posting: # 5973
Views: 8,142
 

 Appropriate Biological matrix for BA/BE studies

Dear all,

❝ Whole blood makes only sense if the drug is extensively bound to erythrocytes and essentially no concentrations would be found in plasma (one of the rare examples is chlorthalidone).


I think regulators would expect whole blood to be used for some drugs which are traditionally measured in whole blood for therapeutic drug monitoring, such as ciclosporin or tacrolimus, independently on whether they can nowadays be measured in plasma or not. Bortezomib would probably be a candidate for whole blood too.

Regards
Ohlbe

Regards
Ohlbe
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2010-10-01 16:46
(5750 d 06:40 ago)

@ Ohlbe
Posting: # 5974
Views: 8,131
 

 TDM matrix

Dear Ohlbe,

THX, valuable advice!

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Ohlbe
★★★

France,
2010-10-01 19:41
(5750 d 03:45 ago)

@ Helmut
Posting: # 5975
Views: 8,130
 

 TDM matrix

Dear Helmut,

By the way, I checked on the FDA web site. They recommend whole blood for tacrolimus. I couldn't find a guidance for ciclosporin (I'm a bit surprised) or bortezomib (more recent drug).

Regards
Ohlbe

Regards
Ohlbe
sambasivarao
☆    

2010-10-06 08:06
(5745 d 15:20 ago)

(edited on 2010-10-06 10:11)
@ Helmut
Posting: # 6003
Views: 8,084
 

 Appropriate Biological matrix for BA/BE studies

Thank you very much for your valuable information


Edit: Full quote removed. Please delete anything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Ohlbe]
jchapdelaine
☆    

2011-02-03 19:08
(5625 d 03:18 ago)

@ sambasivarao
Posting: # 6549
Views: 7,654
 

 Appropriate Biological matrix for BA/BE studies

Is there any publications/literature on the acceptability of using serum or plasma for BE studies? I have an issue as the FDA recently posted a BE recommendation for an analyte stating the use of plasma, however we previously validated the assay using serum. Any help to justify this is welcomed.
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2011-02-05 20:11
(5623 d 02:15 ago)

@ jchapdelaine
Posting: # 6563
Views: 7,568
 

 Serum vs. plasma

Dear John,

please see the Policy.

❝ Is there any publications/literature on the acceptability of using serum or plasma for BE studies?


AFAIK no.

❝ I have an issue as the FDA recently posted a BE recommendation for an analyte stating the use of plasma,


I didn't check all 795 specific guidances, but the FDA seems to generally recommend plasma.

❝ […] however we previously validated the assay using serum.


I guess you don't want to ask FDA (might take ages to get a 'nonbinding' answer)?
From a PK point of view it makes absolutely no difference whether you analyze serum or plasma. Since you have a validated method, you obviously bypassed the drawbacks of using serum mentioned here. Method transfer from plasma to serum is easy, but the other way 'round cumbersome. :-(

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
376 visitors (0 registered, 376 guests [including 82 identified bots]).
Forum time: 23:27 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5